CLARIVATE PLC(CLVT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CLVT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for CLARIVATE PLC (CLVT), a Technology sector company. CLVT is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), CLARIVATE PLC reports quarterly revenue of $585.5M, net income of $-40.2M, an operating margin of 5.2%. Top institutional holders of CLVT by reported 13-F value include Leonard Green & Partners, L.P., Exor N.V., Clarkston Capital Partners,, based on the most recent SEC filings. CLVT trades on the NYSE exchange and files with the SEC under CIK 1764046. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CLARIVATE PLC directly from SEC EDGAR.
Revenue
Q1 2026
$585.5M
Net Income
Q1 2026
$-40.2M
Free Cash Flow
Q1 2026
$78.9M
Operating Margin
Q1 2026
5.2%
ROIC
Q1 2026
0.3%
D/E Ratio
Q1 2026
0.89
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-6.6% YoYNet Income
+77.9% YoYOperating Income
+109.7% YoYEPS (Diluted)
+79.6% YoYTotal Assets
-12.9% YoYTotal Debt
-6.3% YoYOp. Cash Flow
-15.5% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $2.46B -6.6% | $2.63B -1.2% | $2.66B +112.1% | $1.25B +28.7% | $974.3M +0.6% | $968.5M |
| Net Income | $-201.1M +77.9% | $-911.2M +77.0% | $-3.96B -1029.5% | $-350.6M -35.6% | $-258.6M -6.8% | $-242.2M |
| Operating Income | $71.5M +109.7% | $-734.7M +81.3% | $-3.93B -10714.3% | $-36.3M +56.0% | $-82.5M +22.0% | $-105.7M |
| EPS (Diluted) | $-0.30 +79.6% | $-1.47 +76.4% | $-6.24 -661.0% | $-0.82 +12.8% | $-0.94 -11090.5% | $-0.01 |
| Total Assets | $11.07B -12.9% | $12.71B -8.9% | $13.94B -8.2% | $15.20B +300.8% | $3.79B +2.2% | $3.71B |
| Total Debt | $4.42B -6.3% | $4.72B -5.7% | $5.01B +41.3% | $3.54B +114.0% | $1.66B -21.6% | $2.11B |
| Operating Cash Flow | $628.5M -15.5% | $744.2M +46.1% | $509.3M +93.3% | $263.5M +124.1% | $117.6M +550.5% | $-26.1M |
AI Insight: CLVT Financial Trends
CLVT edges toward operating profitability but revenue has contracted sequentially for two straight quarters while equity erosion continues.
• Operating income improved from -$240M in Q2 2024 to $30M in Q1 2026, marking a sustained recovery toward breakeven.
• Total debt declined from $4,658M in Q2 2024 to $4,283M in Q1 2026, a reduction of ~$375M over eight quarters.
• Revenue slipped from $663M in Q4 2024 to $586M in Q1 2026, with no quarter since exceeding that peak.
• Equity has steadily eroded from $5,605M in Q2 2024 to $4,789M in Q1 2026, a cumulative decline of ~$816M.
⚠ Operating cash flow fell to $116M in Q2 2025 and $135M in Q1 2026 — below the $171–$203M range seen in prior quarters.
⚠ Net income turned barely positive at $3M in Q4 2025 but swung back to -$40M in Q1 2026 — profitability remains fragile.
⚠ Debt ticked up $3M quarter-over-quarter in Q4 2025, interrupting the deleveraging trend worth monitoring in coming quarters.
AI Insight: CLVT Ratio Trends
Clarivate's operating margin has climbed out of deeply negative territory, but net losses persist and ROIC remains barely positive, signaling recovery is fragile.
• Operating margin recovered sharply from -36.9% in Q2 2024 to a TTM of 5.0%, marking a meaningful directional improvement.
• Net profit margin remains negative in all but Q4 2025 (0.5%), with the TTM reading still at -5.6%, indicating persistent bottom-line losses.
• ROIC turned positive by Q3 2025 (1.9%) after troughing at -9.3% in Q2 2024, though remains well below any meaningful cost-of-capital hurdle.
• D/E has been range-bound between 0.83 and 0.91 across all periods, showing no meaningful deleveraging progress.
⚠ ROIC slipped to 1.3% in Q1 2026 from 1.8–1.9% in Q3–Q4 2025 — early sign the profitability recovery may be stalling.
⚠ Q4 2025 was the only quarter with positive NPM (0.5%); Q1 2026 reverted to -6.9%, flagging potential seasonality or one-off dependency.
⚠ Leverage (D/E ~0.90) remains elevated with no reduction trend — limits financial flexibility if operating recovery falters.
Get alerted when CLVT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CLARIVATE PLC including:
Top Institutional Holders of CLVT
Leonard Green & Partners, L.P.
$295.2M116,666,507 shExor N.V.
$170.3M67,294,884 shClarkston Capital Partners, LLC
$108.4M42,846,530 shPartners Group Holding AG
$64.7M25,583,059 shFIL Ltd
$63.9M25,266,152 shBlackRock, Inc.
$53.3M21,063,883 shDIMENSIONAL FUND ADVISORS LP
$51.1M20,216,351 shEDMOND DE ROTHSCHILD HOLDING S.A.
$45.1M17,819,740 shCITADEL ADVISORS LLC
$44.7M17,686,947 shInvenomic Capital Management LP
$33.7M13,310,234 sh
| Fund | Value | Shares |
|---|---|---|
| Leonard Green & Partners, L.P. | $295.2M | 116,666,507 |
| Exor N.V. | $170.3M | 67,294,884 |
| Clarkston Capital Partners, LLC | $108.4M | 42,846,530 |
| Partners Group Holding AG | $64.7M | 25,583,059 |
| FIL Ltd | $63.9M | 25,266,152 |
| BlackRock, Inc. | $53.3M | 21,063,883 |
| DIMENSIONAL FUND ADVISORS LP | $51.1M | 20,216,351 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $45.1M | 17,819,740 |
| CITADEL ADVISORS LLC | $44.7M | 17,686,947 |
| Invenomic Capital Management LP | $33.7M | 13,310,234 |
More Technology Companies
View all Technology →Put CLVT on your watchlist
Track score changes the day CLARIVATE PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CLVT a good stock to buy?
13F Pro's AI-powered analysis of CLARIVATE PLC (CLVT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CLVT are available on the CLVT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CLVT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CLVT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CLARIVATE PLC's investment landscape.